N | Overall | No-event | 3p-mace event | P value |
---|---|---|---|---|
300 | 269 | 31 | Â | |
Demographics | ||||
 Age, years | 65.3 ± 10.2 | 65.2 ± 10.1 | 65.9 ± 11.1 | 0.708 |
 Male | 193 (64.3%) | 176 (65.4%) | 17 (54.8%) | 0.244 |
 BMI (kg/m2) | 24.9 ± 2.4 | 24.9 ± 2.4 | 24.9 ± 2.5 | 0.975 |
 Systolic BP, mmHg | 133.6 ± 22.3 | 133.2 ± 22.6 | 137.5 ± 19.2 | 0.316 |
 Diastolic BP, mmHg | 77.7 ± 13.5 | 77.7 ± 13.6 | 78.2 ± 12.0 | 0.838 |
 Heart Rate, | 82.1 ± 16.4 | 81.8 ± 16.5 | 84.9 ± 15.5 | 0.314 |
Medical history | ||||
 Diabetes duration, years | 9.8 ± 7.0 | 9.7 ± 7.0 | 10.9 ± 6.8 | 0.366 |
 Hypertension | 206 (68.7%) | 180 (66.9%) | 26 (83.9%) | 0.054 |
 Stroke | 28 (9.3%) | 24 (8.9%) | 4 (12.9%) | 0.471 |
 ACEI/ARB | 92 (30.7%) | 80 (29.7%) | 12 (38.7%) | 0.305 |
 Insulin | 98 (32.7%) | 84 (31.2%) | 4 (45.2%) | 0.117 |
Laboratory values | ||||
 HbA1c, (%) | 8.0 ± 1.8 | 7.9 ± 1.7 | 8.7 ± 2.4 | 0.013 |
 Fasting glucose, mmol/L | 9.2 ± 4.2 | 9.1 ± 3.9 | 10.4 ± 5.8 | 0.095 |
 TC, mmol/L | 4.5 ± 1.2 | 4.5 ± 1.2 | 4.6 ± 1.2 | 0.881 |
 TG, mmol/L | 1.9 ± 1.2 | 1.8 ± 1.2 | 2.0 ± 1.4 | 0.514 |
 HDL-C, mmol/L | 1.1 ± 0.3 | 1.0 ± 0.3 | 1.1 ± 0.4 | 0.080 |
 LDL-C, mmol/L | 2.8 ± 0.9 | 2.8 ± 0.9 | 2.7 ± 0.8 | 0.629 |
 eGFR, mL/min/1.73 m2 | 83.4 ± 38.8 | 84.2 ± 39.2 | 76.1 ± 35.1 | 0.268 |
 BNP (pg/ml) | 391.1 ± 680.8 | 395.1 ± 708.4 | 356.8 ± 366.6 | 0.767 |
 LVEF, % | 59.6 ± 13.9 | 59.7 ± 14.3 | 58.9 ± 9.7 | 0.762 |
Angiographic data | ||||
 Gensini score | 55.6 ± 41.5 | 54.8 ± 41.5 | 62.5 ± 41.2 | 0.328 |
 Myocardial infarction | 102 (34.0%) | 92 (34.2%) | 10 (32.3%) | 0.829 |
 PCI | 179 (59.7%) | 160 (59.5%) | 19 (61.3%) | 0.846 |
Severity of CHD | Â | Â | Â | 0.580 |
 Mild | 92 (30.7%) | 84 (31.2%) | 8 (25.8%) |  |
 Moderate | 70 (23.3%) | 64 (23.8%) | 6 (19.4%) |  |
 Sever | 138 (46.0%) | 121 (45.0%) | 17 (54.8%) |  |